Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Clemmons

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Endocrinology|December 26, 2001
Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actionsTaek Nam, Anna Moralez, David Clemmons
Journal of Diabetes Research|May 4, 2019
Inhibition of Aberrant IGF-I Signaling in Diabetic Male Rat Retina Prevents and Reverses Changes of Diabetic RetinopathyGang Xi, Christine Wai, David Clemmons
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 14, 2010
IGF-1 and bone: New discoveries from mouse modelsShoshana Yakar, Hayden-William Courtland, David Clemmons
Endocrinology|May 15, 2003
Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cellsAnna Moralez, Walker H Busby, David Clemmons
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled studySteven Grinspoon, Karen Miller, David Herzog, et al.
Endocrinology|June 11, 2010
Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cellsGang Xi, Xinchun Shen, Yashwanth Radhakrishnan, et al.
Current Diabetes Reviews|June 29, 2011
Igf-I signaling in response to hyperglycemia and the development of diabetic complicationsDavid Clemmons, Laura Maile, Gang Xi, et al.
Journal of Diabetes Research|November 13, 2014
Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic ratsLaura A Maile, Katherine Gollahon, Christine Wai, et al.
Frontiers in Endocrinology|January 9, 2023
Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparationMartin Bidlingmaier, Beverly M K Biller, David Clemmons, et al.
Frontiers in Endocrinology|March 20, 2023
Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparationMartin Bidlingmaier, Beverly M K Biller, David Clemmons, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Endocrinology|December 26, 2001
Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actionsTaek Nam, Anna Moralez, David Clemmons
Journal of Diabetes Research|May 4, 2019
Inhibition of Aberrant IGF-I Signaling in Diabetic Male Rat Retina Prevents and Reverses Changes of Diabetic RetinopathyGang Xi, Christine Wai, David Clemmons
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 14, 2010
IGF-1 and bone: New discoveries from mouse modelsShoshana Yakar, Hayden-William Courtland, David Clemmons
Endocrinology|May 15, 2003
Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cellsAnna Moralez, Walker H Busby, David Clemmons
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled studySteven Grinspoon, Karen Miller, David Herzog, et al.
Endocrinology|June 11, 2010
Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cellsGang Xi, Xinchun Shen, Yashwanth Radhakrishnan, et al.
Current Diabetes Reviews|June 29, 2011
Igf-I signaling in response to hyperglycemia and the development of diabetic complicationsDavid Clemmons, Laura Maile, Gang Xi, et al.
Journal of Diabetes Research|November 13, 2014
Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic ratsLaura A Maile, Katherine Gollahon, Christine Wai, et al.
Frontiers in Endocrinology|January 9, 2023
Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparationMartin Bidlingmaier, Beverly M K Biller, David Clemmons, et al.
Frontiers in Endocrinology|March 20, 2023
Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparationMartin Bidlingmaier, Beverly M K Biller, David Clemmons, et al.
Pageof 3